Columbia Labs (CBRX) Sells STRIANT to Actient
Tweet Send to a Friend
Columbia Laboratories, Inc. (Nasdaq: CBRX) entered an asset purchase agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
